ARK Investment Management’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,124,483
| Closed | -$1.11M | – | 197 |
|
|
2025
Q1 | $1.11M | Sell |
1,124,483
-875,514
| -44% | -$863K | 0.01% | 168 |
|
|
2024
Q4 | $2.62M | Sell |
1,999,997
-509,740
| -20% | -$668K | 0.02% | 123 |
|
|
2024
Q3 | $8.63M | Sell |
2,509,737
-120,627
| -5% | -$415K | 0.08% | 101 |
|
|
2024
Q2 | $8.68M | Sell |
2,630,364
-73,419
| -3% | -$242K | 0.08% | 99 |
|
|
2024
Q1 | $12.7M | Sell |
2,703,783
-117,777
| -4% | -$555K | 0.09% | 99 |
|
|
2023
Q4 | $20.6M | Buy |
2,821,560
+200,677
| +8% | +$1.46M | 0.12% | 81 |
|
|
2023
Q3 | $31.7M | Sell |
2,620,883
-7,190
| -0.3% | -$86.9K | 0.24% | 51 |
|
|
2023
Q2 | $27.8M | Sell |
2,628,073
-109,251
| -4% | -$1.16M | 0.18% | 67 |
|
|
2023
Q1 | $26.9M | Buy |
2,737,324
+309,269
| +13% | +$3.04M | 0.19% | 56 |
|
|
2022
Q4 | $35.7M | Sell |
2,428,055
-203,973
| -8% | -$3M | 0.31% | 45 |
|
|
2022
Q3 | $31.9M | Sell |
2,632,028
-147,303
| -5% | -$1.79M | 0.22% | 60 |
|
|
2022
Q2 | $25.5M | Sell |
2,779,331
-95,984
| -3% | -$881K | 0.15% | 78 |
|
|
2022
Q1 | $40.9M | Sell |
2,875,315
-105,521
| -4% | -$1.5M | 0.17% | 75 |
|
|
2021
Q4 | $62.9M | Buy |
2,980,836
+14,097
| +0.5% | +$297K | 0.19% | 74 |
|
|
2021
Q3 | $77.8M | Buy |
2,966,739
+939,579
| +46% | +$24.7M | 0.19% | 81 |
|
|
2021
Q2 | $63.2M | Buy |
2,027,160
+668,571
| +49% | +$20.8M | 0.12% | 112 |
|
|
2021
Q1 | $41.7M | Buy |
1,358,589
+723,196
| +114% | +$22.2M | 0.08% | 143 |
|
|
2020
Q4 | $21.8M | Buy |
+635,393
| New | +$21.8M | 0.06% | 135 |
|